The new treatment from Seres Therapeutics provides a simpler, rigorously tested version of stool-based procedures that some medical specialists have used for more than a decade to help patients.
While it’s highly experimental, surprising early research suggests it may reprogram misfiring heart cells to control heartbeats more like younger, healthier cells do.
A British Columbia company offering health services to patients who pay annual fees starting at $4,650 has agreed to modify its policies, averting a court challenge over public healthcare, says the province’s health minister.
Michelle Logeot refers to the biggest health scare of her life as 'the event,' the type she does not want other women to experience when doctors misdiagnose them or dismiss symptoms of a potentially deadly heart attack.
Canadian specialty pharmaceutical company Juno Pharmaceuticals has partnered with U.K.-based Rosemont Pharmaceuticals to bring more specialty liquid medicines into the country.
Currently in its third reading, Bill 60, would allow the appointment of directors to regulate for-profit clinics while hospitals could approve the outsourcing of specific surgeries and diagnostic procedures to these private medical facilities.
